Human antibodies from transgenic animals.
Abstract
Laboratory mice provide a ready source of diverse, high-affinity and high-specificity monoclonal antibodies (mAbs). However, development of rodent antibodies as therapeutic agents has been impaired by the inherent immunogenicity of these molecules. One technology that has been explored to generate low immunogenicity mAbs for in vivo therapy involves the use of transgenic mice expressing repertoires of human antibody gene sequences. This technology has now been exploited by over a dozen different pharmaceutical and biotechnology companies toward developing new therapeutic mAbs, and currently at least 33 different drugs in clinical testing--including several in pivotal trials--contain variable regions encoded by human sequences from transgenic mice. The emerging data from these trials provide an early glimpse of the safety and efficacy issues for these molecules. Nevertheless, actual product approval, the biggest challenge so far, is required to fully validate this technology as a drug discovery tool. In the future, it may be possible to extend this technology beyond rodents and use transgenic farm animals to directly generate and produce human sequence polyclonal sera.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Denosumab and many other fully human therapeutic antibodies are produced in transgenic mice in which murine Ig genes have been deleted and replaced with human orthologs.
“Denosumab and numerous other fully human therapeutic antibodies have been made in transgenic mice, wherein their murine Ig genes have been deleted and replaced with human orthologs (431, 432).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [432]
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
Köhler, G., & Milstein, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,200 · see citing works
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035 · see citing works
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955 · see citing works
Phage antibodies: filamentous phage displaying antibody variable domains
McCafferty, J., Griffiths, A. D., Winter, G. P., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,427 · see citing works
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Assche, G. V., Haens, G. D., Carbonez, A., & Rutgeerts, P. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,012 · see citing works
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683 · see citing works
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575 · see citing works
Replacing the complementarity-determining regions in a human antibody with those from a mouse
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406 · see citing works
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
Morrison, S. L., Johnson, M. J., Herzenberg, L. A., & Oi, V. T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.21.6851 · Cited by 1,040 · see citing works
Hodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830997100 · Cited by 1,006 · see citing works
Anti–Interleukin-12 Antibody for Active Crohn's Disease
Mannon, P., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D. H., Dolin, B. J., Goodman, N., Groden, C. A., Hornung, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033402 · Cited by 844 · see citing works
Diversity in the CDR3 Region of VH Is Sufficient for Most Antibody Specificities
Xu, J. L., & Davis, M. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00006-6 · Cited by 779 · see citing works
Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040305 · Cited by 770 · see citing works
Ortho Multicenter Transplant Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198508083130601 · Cited by 720 · see citing works
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697 · see citing works
Teeling, J. L. (2004) · Blood · doi:10.1182/blood-2004-01-0039 · Cited by 630 · see citing works
Structure-Immunogenicity Relationships of Therapeutic Proteins
Hermeling, S., Crommelin, D. J. A., Schellekens, H., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029275.41323.a6 · Cited by 617 · see citing works
Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
Yang, X. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00134-7 · Cited by 463 · see citing works
Sanderson, K. M., Scotland, R., Lee, P. P., Liu, D., Groshen, S. G., Snively, J., Sian, S., Nichol, G. M., Davis, T. A., Keler, T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.128 · Cited by 432 · see citing works
Antigen-specific human antibodies from mice comprising four distinct genetic modifications
Lönberg, N., Taylor, L. D., Harding, F., Trounstine, M. L., Higgins, K. M., Schramm, S. R., Kuo, C.-C., Mashayekh, R., Wymore, K., McCabe, J. G., et al. (1994) · Nature · doi:10.1038/368856a0 · Cited by 399 · see citing works
Mendez, M. J., Green, L. L., Corvalán, J. R. F., Jia, X., Maynard-Currie, C. E., Yang, X.-D., Gallo, M., Louie, D. M., Lee, D. V., Erickson, K. L., et al. (1997) · Nature Genetics · doi:10.1038/ng0297-146 · Cited by 376 · see citing works
Kinetic and affinity limits on antibodies produced during immune responses.
Foote, J., & Eisen, H. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1254 · Cited by 375 · see citing works
Cohen, B. D., Baker, D. A., Soderstrom, C. I., Tkalcevic, G. T., Rossi, A. M., Miller, P. E., Tengowski, M. W., Wang, F., Gualberto, A., BEEBE, J. S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1070 · Cited by 367 · see citing works
Huang, S., Mills, L., Mian, B. M., Tellez, C. S., McCarty, M. F., Yang, X., Gudas, J. M., & Bar‐Eli, M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64164-8 · Cited by 361 · see citing works
Green, L. L., Hardy, M. C., Maynard-Currie, C. E., Tsuda, H., Louie, D. M., Mendez, M. J., Abderrahim, H., Noguchi, M., Smith, D. H., Zeng, Y. C., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-13 · Cited by 355 · see citing works
Zijlstra, M., Li, E., Sajjadi, F., Subramani, S., & Jaenisch, R. (1989) · Nature · doi:10.1038/342435a0 · Cited by 347 · see citing works
Rowinsky, E. K., Schwartz, G. H., Gollob, J., Thompson, J. A., Vogelzang, N. J., Figlin, R. A., Bukowski, R. M., Haas, N. B., Lockbaum, P., Li, Y.-P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.061 · Cited by 329 · see citing works
Yang, X., Jia, X., Corvalan, J. R. F., Wang, P., Davis, C., & Jakobovits, A. (1999) · PubMed · Cited by 328 · see citing works
Current Status and Future Prospects
Wood, C. E., Baker, G., & Trounson, A. (1984) · Springer eBooks · doi:10.1007/978-1-4471-3317-9_2 · Cited by 306 · see citing works
Germ-Line Transmission of a c- abl Mutation Produced by Targeted Gene Disruption in ES Cells
Schwartzberg, P. L., Goff, S. P., & Robertson, E. J. (1989) · Science · doi:10.1126/science.2554496 · Cited by 272 · see citing works
Cloned transchromosomic calves producing human immunoglobulin
Kuroiwa, Y., Kasinathan, P., Choi, Y. J., et al. (2002) · Nature Biotechnology · doi:10.1038/nbt727 · Cited by 268 · see citing works
Functional expression and germline atransmission of a human chromosome fragment in chimaeric mice
Tomizuka, K., Yoshida, H., Uejima, H., Kugoh, H., Sato, K., Ohguma, A., Hayasaka, M., Hanaoka, K., Oshimura, M., & Ishida, I. (1997) · Nature Genetics · doi:10.1038/ng0697-133 · Cited by 267 · see citing works
High-avidity human IgGκ monoclonal antibodies from a novel strain of minilocus transgenic mice
Fishwild, D. M., O'Donnell, S. L., Bengoechea, T. G., Hudson, D., Harding, F., Bernhard, S. L., Jones, D., Kay, R. M., Higgins, K. M., Schramm, S. R., et al. (1996) · Nature Biotechnology · doi:10.1038/nbt0796-845 · Cited by 266 · see citing works
Human monoclonal antibody production
James, K. E., & Bell, G. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90170-0 · Cited by 223 · see citing works
Foon, K. A., Yang, X.-D., Weiner, L. M., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.098 · Cited by 218 · see citing works
Tomizuka, K., Shinohara, T., Yoshida, H., Uejima, H., Ohguma, A., Tanaka, S., Sato, K., Oshimura, M., & Ishida, I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.722 · Cited by 202 · see citing works
Roost, H.-P., Bachmann, M. F., Haag, A. F., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1257 · Cited by 199 · see citing works
The Imprint of Somatic Hypermutation on the Repertoire of Human Germline V Genes
Tomlinson, I. M., Walter, G., Jones, P., Dear, P. H., Sonnhammer, E. L. L., & Winter, G. P. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0127 · Cited by 197 · see citing works
Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model
Villadsen, L. S., Schuurman, J., Beurskens, F. J. M., Dam, T. N., Dagnæs‐Hansen, F., Skov, L., Rygaard, J., Voorhorst‐Ogink, M. M., Gerritsen, A. F., van Dijk, M. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318986 · Cited by 193 · see citing works
Kuus-Reichel, K., Grauer, L. S., Karavodin, L. M., Knott, C., Krusemeier, M., & Kay, N. E. (1994) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.1.4.365-372.1994 · Cited by 185 · see citing works
Sequential targeting of the genes encoding immunoglobulin-μ and prion protein in cattle
Kuroiwa, Y., Kasinathan, P., Matsushita, H., et al. (2004) · Nature Genetics · doi:10.1038/ng1373 · Cited by 179 · see citing works
Yang, X., Corvalán, J. R. F., Wang, P., Roy, C. M.-N., & Davis, C. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.3.401 · Cited by 174 · see citing works
Cytotoxic T Lymphocyte-Associated Antigen 4 Blockade in Patients with Metastatic Melanoma
Robinson, M. R., Chan, C. C., Yang, J. C.-H., Rubin, B. I., Gracia, G. J., Sen, H. N., Csaky, K. G., & Rosenberg, S. A. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200411000-00008 · Cited by 159 · see citing works
Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts
Kuroiwa, Y., Tomizuka, K., Shinohara, T., et al. (2000) · Nature Biotechnology · doi:10.1038/80287 · Cited by 155 · see citing works
A repertoire of monoclonal antibodies with human heavy chains from transgenic mice.
Brüggemann, M., Caskey, H. M., Teale, C., et al. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6709 · Cited by 153 · see citing works
Trikha, M., Zhao, Z., Nemeth, J. A., Chen, Q., Sharp, C. M., Emmell, E., Giles-Komar, J. M., & Nakada, M. T. (2004) · International Journal of Cancer · doi:10.1002/ijc.20116 · Cited by 153 · see citing works
Bleeker, W. K., van Bueren, J. J. L., van Ojik, H. H., Gerritsen, A. F., Pluyter, M., Houtkamp, M., Halk, E., Goldstein, J., Schuurman, J., van Dijk, M. A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4699 · Cited by 151 · see citing works
Mian, B. M., Dinney, C. P., Bermejo, C. E., Sweeney, P., Tellez, C. S., Yang, X., Gudas, J. M., McConkey, D. J., & Bar‐Eli, M. (2003) · PubMed · Cited by 148 · see citing works
Immunogenicity of therapeutic monoclonal antibodies.
Pendley, C. E., Schantz, A., & Wagner, C. (2003) · PubMed · Cited by 144 · see citing works
Activity and Safety of CTLA-4 Blockade Combined with Vaccines in Cynomolgus Macaques
Keler, T., Halk, E., Vitale, L. A., O’Neill, T., Blanset, D. L., Lee, S., Srinivasan, M., Graziano, R. F., Davis, T. A., Lönberg, N., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6251 · Cited by 134 · see citing works
Production of Human Monoclonal and Polyclonal Antibodies in TransChromo Animals
Ishida, I., Tomizuka, K., Yoshida, H., et al. (2002) · Cloning and Stem Cells · doi:10.1089/153623002753632084 · Cited by 132 · see citing works
The creation of diversity in the human immunoglobulin Vλ repertoire
Ignatovich, O., Tomlinson, I. M., Jones, P. T., & Winter, G. P. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0956 · Cited by 130 · see citing works
Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome
Tzipori, S., Sheoran, A. S., Akiyoshi, D. E., et al. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.926-941.2004 · Cited by 126 · see citing works
Ribas, A., Glaspy, J. A., Lee, Y., Dissette, V. B., Seja, E., Vu, H. T., Tchekmedyian, N. S., Oseguera, D. K., Comin-Anduix, B., Wargo, J. A., et al. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200409000-00004 · Cited by 119 · see citing works
Ramakrishna, V., Treml, J., Vitale, L. A., Connolly, J. E., O’Neill, T. J., Smith, P. A., Jones, C. L., He, L.-Z., Goldstein, J., Wallace, P. K., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2845 · Cited by 114 · see citing works
The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma
Borchmann, P., Treml, J., Hansen, H. P., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0515 · Cited by 114 · see citing works
Mukherjee, J., Chios, K., Fishwild, D. M., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.612-619.2002 · Cited by 111 · see citing works
Houghton, A. N., Brooks, H., Côté, R. J., et al. (1983) · The Journal of Experimental Medicine · doi:10.1084/jem.158.1.53 · Cited by 110 · see citing works
Feeney, A. J., Atkinson, M. J., Cowan, M. J., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118669 · Cited by 106 · see citing works
Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies
Zou, Y.-R., Müller, W., Gu, H., & Rajewsky, K. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00248-7 · Cited by 104 · see citing works
Kraj, P. J., Rao, S. P., Glas, A. M., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5824 · Cited by 102 · see citing works
Ostendorf, T., van Roeyen, C. R. C., Peterson, J. D., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000083393.00959.02 · Cited by 95 · see citing works
Schüler, W., Bigaud, M., Brinkmann, V., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000116563.72763.83 · Cited by 90 · see citing works
Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
Kline, G. H., Hartwell, L., Beck‐Engeser, G., et al. (1998) · PubMed · Cited by 86 · see citing works
Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2
Mori, E., Thomas, M., Motoki, K., Nakazawa, K., Tahara, T., Tomizuka, K., Ishida, I., & Kataoka, S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401331 · Cited by 84 · see citing works
Pre-B Cell Receptor-Mediated Selection of Pre-B Cells Synthesizing Functional μ Heavy Chains
Kline, G. H., Hartwell, L., Beck-Engeser, G. B., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1608 · Cited by 83 · see citing works
Taylor, L. D., Carmack, C. E., Huszar, D., et al. (1994) · International Immunology · doi:10.1093/intimm/6.4.579 · Cited by 75 · see citing works
The evolutionary and structural ‘logic’ of antigen receptor diversity
Davis, M. M. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.08.003 · Cited by 69 · see citing works
Skov, L., Kragballe, K., Zachariae, C. O. C., et al. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.11.1433 · Cited by 68 · see citing works
Moulton, L. H., Chung, S.-E., Croll, J., Reid, R., Weatherholtz, R., & Santosham, M. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.4.753 · Cited by 68 · see citing works
Adderson, E. E., Shackelford, P. G., Insel, R. A., et al. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115649 · Cited by 67 · see citing works
Production and Characterization of Protective Human Antibodies against Shiga Toxin 1
Mukherjee, J., Chios, K., Fishwild, D. M., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5896-5899.2002 · Cited by 62 · see citing works
PSMA specific antibodies and their diagnostic and therapeutic use
Holmes, E. H. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.3.511 · Cited by 60 · see citing works
A Human Immunoglobulin λ Locus Is Similarly Well Expressed in Mice and Humans
Popov, A. V., Zou, X., Xian, J., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1611 · Cited by 58 · see citing works
Maitta, R. W., Datta, K., Chang, Q., Luo, R. X., Witover, B., Subramaniam, K. S., & Pirofski, L. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4810-4818.2004 · Cited by 57 · see citing works
He, Y., Honnen, W. J., Krachmarov, C. P., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.595 · Cited by 56 · see citing works
Nicholson, I., Zou, X., Popov, A. V., et al. (1999) · PubMed · Cited by 55 · see citing works
Nadel, B., Tang, A. Y. B., Lugo‐Villarino, G., Love, V. A., Escuro, G., & Feeney, A. J. (1998) · PubMed · Cited by 55 · see citing works
High efficiency creation of human monoclonal antibody-producing hybridomas
Dessain, S. K., Adekar, S. P., Stevens, J. B., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.05.005 · Cited by 50 · see citing works
Nicholson, I., Zou, X., Popov, A. V., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6898 · Cited by 50 · see citing works
Nadel, B., Tang, A. Y. B., Lugo‐Villarino, G., Love, V. A., Escuro, G., & Feeney, A. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6068 · Cited by 50 · see citing works
Green, L. L., & Jakobovits, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.483 · Cited by 48 · see citing works
Prospects for the therapeutic use of human monoclonal antibodies.
Larrick, J. W., & Bourla, J. M. (1986) · PubMed · Cited by 48 · see citing works
Chang, Q., Zhong, Z., Lees, A., Pekna, M., & Pirofski, L. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.4977-4986.2002 · Cited by 46 · see citing works
Harris, J. F., Hawley, R. G., Hawley, T. S., et al. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90173-q · Cited by 45 · see citing works
Olsson, L., Andreasen, R. B., Öst, Å., et al. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.159.2.537 · Cited by 44 · see citing works
Immunoglobulin genes in transgenic mice
Alt, F. W., Blackwell, T. K., & Yancopoulos, G. D. (1985) · Trends in Genetics · doi:10.1016/0168-9525(85)90089-7 · Cited by 41 · see citing works
Idiopathic thrombocytopenic purpura in pregnancy
Sainio, S., Joutsi, L., Järvenpää, A., et al. (1998) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1998.770303.x · Cited by 41 · see citing works
Destabilizing loop swaps in the CDRs of an immunoglobulin VL domain
Helms, L. R., & Wetzel, R. B. (1995) · Protein Science · doi:10.1002/pro.5560041012 · Cited by 39 · see citing works
Imakiire, T., Kuroki, M., Kuroki, M., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11608 · Cited by 38 · see citing works
Macdonald, P. S., Mundy, J. A., KEOGH, A. M., et al. (1993) · Transplantation · doi:10.1097/00007890-199301000-00021 · Cited by 37 · see citing works
Antibody Producing Human-Human Hybridomas
Olsson, L. (1984) · Springer eBooks · doi:10.1007/978-1-4684-4649-4_18 · Cited by 35 · see citing works
Heuck, F., Ellermann, J., Borchmann, P., et al. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200409000-00003 · Cited by 35 · see citing works
Lucas, A. H., Larrick, J. W., & Reason, D. C. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.3873-3880.1994 · Cited by 35 · see citing works
Zou, X., Piper, T. A., Smith, J. A., Allen, N. D., Xian, J., & Brüggemann, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1354 · Cited by 32 · see citing works
Constraints on the Hydropathicity and Sequence Composition of HCDR3 are Conserved Across Evolution
Link, J. M., Ivanov, I. I., Ippolito, G. C., et al. (2002) · CRC Press eBooks · doi:10.1201/9780203216514.ch3 · Cited by 28 · see citing works
Ambrosino, D. M., Barrus, V. A., DeLange, G. G., et al. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112585 · Cited by 25 · see citing works
Fishwild, D. M., Hudson, D., Deshpande, U., et al. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4734 · Cited by 23 · see citing works
Clinical experience with monoclonal antibodies to epidermal growth factor receptor
Calvo, E., & Rowinsky, E. K. (2005) · Current Oncology Reports · doi:10.1007/s11912-005-0034-9 · Cited by 21 · see citing works
Isolation and Characterization of Human Monoclonal Antibodies to Digoxin
Ball, W. J., Kasturi, R., Dey, P., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2291 · Cited by 20 · see citing works
Chung, G. H., Scott, M. G., Kim, K. H., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4352 · Cited by 18 · see citing works
Suzuki, N., Aoki, D., Tamada, Y., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.06.024 · Cited by 18 · see citing works
Class Switching in Human Immunoglobulin Transgenic Mice
Harding, F., & Lönberg, N. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb55879.x · Cited by 17 · see citing works
Garambois, V., Fabienne, G., Foulquier, E., et al. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-75 · Cited by 15 · see citing works
Nozawa, S., Aoki, D., Tsukazaki, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0802 · Cited by 14 · see citing works
Ren, L., Zou, X., Smith, J. A., & Brüggemann, M. (2004) · Genomics · doi:10.1016/j.ygeno.2004.06.008 · Cited by 12 · see citing works
Idiopathic thrombocytopenic purpura in pregnancy. Successful management with immunoglobulin infusion
Rose, V. L. (1985) · JAMA · doi:10.1001/jama.254.18.2626 · Cited by 12 · see citing works
Farr, C. D., Tabet, M. R., Ball, W. J., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0102811 · Cited by 10 · see citing works
Monoclonal antibody-based immunotherapy of Hodgkin's lymphoma.
Borchmann, P., Schnell, R., Schulz, H., et al. (2004) · PubMed · Cited by 8 · see citing works
Suárez, E., Yáñez, R., Barrios, Y., et al. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.035 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824 · see citing works
Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies
Wang, X., Das, T. K., Singh, S. K., & Kumar, S. (2009) · mAbs · doi:10.4161/mabs.1.3.8035 · Cited by 198 · see citing works
Developments and Challenges for mAb-Based Therapeutics
Goswami, S., Wang, W., Arakawa, T., & Ohtake, S. (2013) · Antibodies · doi:10.3390/antib2030452 · Cited by 144 · see citing works
Human Monoclonal Antibodies: The Benefits of Humanization
Waldmann, H. (2019) · Methods in Molecular Biology · doi:10.1007/978-1-4939-8958-4_1 · Cited by 80 · see citing works
Coughlin, M., Lou, G., Martinez, O., Masterman, S. K., Olsen, O. A., Moksa, A. A., Farzan, M., Babcook, J. S., & Prabhakar, B. S. (2007) · Virology · doi:10.1016/j.virol.2006.09.029 · Cited by 70 · see citing works
Jain, T., Boland, T., Lilov, A., Burnina, I., Brown, M., Xu, Y., & Vásquez, M. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx519 · Cited by 61 · see citing works
Development of scoring functions for antibody sequence assessment and optimization
Seeliger, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076909 · Cited by 24 · see citing works
- Authors
- Lonberg, N.
- Venue
- Nature Biotechnology
- Published
- 2005-09
- Volume
- 23
- Issue
- 9
- Pages
- 1117-1125
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2054383673
- Cited by
- 434
- References
- 110
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 10 · 2023: 20 · 2022: 12 · 2021: 8 · 2020: 17 · 2019: 14 · 2018: 5 · 2017: 17 · 2016: 20 · 2015: 29 · 2014: 29 · 2013: 36 · 2012: 30
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
- Keywords
- humanized monoclonal antibody, transgenic mice, monoclonal antibodies, therapeutic antibodies, immunogenicity, immunoglobulin variable region, antibody drug development
- MeSH terms
- Animals, Antibodies, Antibodies, Monoclonal, Biotechnology, Clinical Trials as Topic, Humans, Immunoglobulins, Immunoglobulin Heavy Chains, Immunoglobulin Light Chains, Mice, Transgenic, Drug Delivery Systems, Animals, Genetically Modified, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review